It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1999.
1999 | Mumbai, Maharashtra, India | ActiveNectar Medipharma Private Limited, a active private limited company, was established on 28 October 1999 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MH1999PTC243788. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kruti Jigar Bathia (Director), Shweta Nipun Sanghavi (Director), Ashish Subhashbhai Desai (Director). Past directors included Bharat Balkrishnan Shah, Jayendra Natverlal Desai, Gunjan Ashokbhai Desai. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No. 204A, Janki Centre, 2Nd Floor, Jeevan Nagar, Off. Veera Desai Road, Andheri West, Mumbai, Maharashtra, 400053.
U24232MH1999PTC243788
243788
28 October 1999
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Nectar Medipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kruti Jigar Bathia | Director | 15 Jan 2015 | Current |
| Shweta Nipun Sanghavi | Director | 15 Jan 2015 | Current |
| Ashish Subhashbhai Desai | Director | 14 Jul 2011 | Current |
| Jayendra Natverlal Desai | Director | 19 Nov 2020 | Current |
| Gunjan Ashokbhai Desai | Director | 14 Oct 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Oct 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 19 Jul 2011 | Past |
| Pramod Abcsdd | Director | 19 Jul 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nectar Medipharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.19% increase. The company also saw a substantial improvement in profitability, with a 111.25% increase in profit. The company's net worth moved up by a moderate rise of 4.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Nectar Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nectar Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nectar Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nectar Medipharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nectar Medipharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Nectar Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Jayendra Natverlal Desai was appointed as a Director was appointed as a Director on 19 Nov 2020 & has been associated with this company since 5 years 9 days . was completed.
Kruti Jigar Bathia was appointed as a Director was appointed as a Director on 15 Jan 2015 & has been associated with this company since 10 years 10 months . was recorded as a recent event.
Progress on Shweta Nipun Sanghavi was appointed as a Director was appointed as a Director on 15 Jan 2015 & has been associated with this company since 10 years 10 months . was documented.
Gunjan Ashokbhai Desai was appointed as a Director was appointed as a Director on 14 Oct 2014 & has been associated with this company since 11 years 1 month . was recorded as a recent event.
The CIN of Nectar Medipharma Private Limited is U24232MH1999PTC243788.
Nectar Medipharma Private Limited is headquartered at No. 204A, Janki Centre, 2Nd Floor, Jeevan Nagar, Off. Veera Desai Road, Andheri West, Mumbai, Maharashtra, 400053.
Nectar Medipharma Private Limited was incorporated on 28 October 1999.
The current directors of Nectar Medipharma Private Limited are
The primary industry of Nectar Medipharma Private Limited is Manufacturing.
Nectar Medipharma Private Limited is unlisted.
The authorized capital of Nectar Medipharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Nectar Medipharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX